PAUL JACKSON: Open Payments
NPI 1285375543 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 37 payments from 12 companies in 2025. Trend: 2023 $379 · 2024 $527 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $210 |
| Merck Sharp & Dohme LLC | 5 | $127 |
| Novo Nordisk Inc | 5 | $120 |
| Astellas Pharma US Inc | 2 | $44 |
| Amgen Inc. | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Organon LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: LEQVIO, VERQUVO, Wegovy, Veozah, LifeVest, CORLANOR, Auvelity, NEXPLANON.
Industry payments across TN — which companies pay providers there.
